BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7987882)

  • 1. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
    Steinhagen-Thiessen E
    Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group.
    Lambrecht LJ; Malini PL
    Acta Cardiol; 1993; 48(6):541-54. PubMed ID: 8122478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P; Kafonek S; Laurora I; Hunninghake D
    Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
    Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
    J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). The European Study Group.
    Am J Cardiol; 1992 Nov; 70(15):1281-6. PubMed ID: 1442579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
    Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group.
    Am J Cardiol; 1993 Jun; 71(16):1408-14. PubMed ID: 8517385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.
    Strauss WE; Lapsley D; Gaziano JM
    Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
    Brown WV; Bays HE; Hassman DR; McKenney J; Chitra R; Hutchinson H; Miller E;
    Am Heart J; 2002 Dec; 144(6):1036-43. PubMed ID: 12486428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover trial of simvastatin versus pravastatin in patients with primary hypercholesterolemia.
    Sasaki S; Sawada S; Nakata T; Itoh H; Takeda K; Nakagawa M; Kuriyama K
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):142-7. PubMed ID: 9268234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
    Lintott CJ; Scott RS; Sutherland WH; Bremer J
    Aust N Z J Med; 1993 Aug; 23(4):381-6. PubMed ID: 8240151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J; Hoffman R; Hanson M; Veltri E
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-masked comparison of the quality of life of hypercholesterolemic men treated with simvastatin or pravastatin. International Quality of Life Multicenter Group.
    Seed M; Weir MR
    Clin Ther; 1999 Oct; 21(10):1758-70. PubMed ID: 10566571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
    Simons LA
    Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
    Ose L; Davidson MH; Stein EA; Kastelein JJ; Scott RS; Hunninghake DB; Campodonico S; Insull W; Escobar ID; Schrott HG; Stepanavage ME; Wu M; Tate AC; Melino MR; Mercuri M; Mitchel YB
    Clin Cardiol; 2000 Jan; 23(1):39-46. PubMed ID: 10680028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.